Скачать или смотреть The Realities of MS Treatment Access and Global Disparities – Dr. Nilüfer Kale

In this segment, Dr. Nilüfer Kale breaks down the real-world challenges behind multiple sclerosis treatment access and why patients around the world still experience major differences in the care they can receive. Even though multiple sclerosis therapies have evolved dramatically, not every healthcare system can provide the same options — and that gap affects long-term outcomes for people living with multiple sclerosis.

Dr. Kale explains how early therapies like interferons for MS and other immunosuppressant drugs for MS laid the foundation for modern disease modifying therapies for MS. But despite this progress, global MS care disparities continue to limit treatment choice. She also touches on how pregnancy considerations in MS treatment complicate decision-making, and why MS healthcare policy plays a central role in determining which drugs become available in different regions.

What You’ll Learn in This Segment
▶ How ms treatment and ms therapy evolution have changed over the last 25 years
▶ Why ms treatments vary between countries and hospitals
▶ How older drugs like interferon compare to today’s therapies
▶ Challenges in ms healthcare access due to policy, cost, and availability
▶ Why pregnancy still influences treatment decisions for women with MS

This conversation offers a clear, practical look at how MS treatment options differ across healthcare systems, why MS treatment guidelines continue to evolve, and what needs to improve so every patient receives safe and effective MS care — no matter where they live.

#multipleSclerosis #MSTreatment #MSHealthcare #Neurology #ChronicIllness #MSAwareness #GlobalHealth #HealthcareAccess #AutoimmuneDisease #DrNiluferKale #MDNewsline